Evidence map›Paper›PMID 36046297›Full record

ReviewCureus2022

When to Use Antibiotics in COVID-19: A Proposal Based on Questions.

Carmelo Dueñas-Castell, Camilo Jose Polanco-Guerra, Maria Cristina Martinez-Ávila, Amilkar J Almanza Hurtado, Tómas Rodriguez Yanez, Juan Camilo Gutierrez-Ariza, Jorge Rico-Fontalvo

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carmelo Dueñas-CastellIntensive Care Medicine, Gestión Salud IPS, Cartagena, COL.
Camilo Jose Polanco-GuerraInternal Medicine, Universidad del Sinú - Elías Bechara Zainúm, Cartagena, COL.
Maria Cristina Martinez-ÁvilaIntensive Care Medicine, Nuevo Hospital de Bocagrande, Cartagena, COL.
Amilkar J Almanza HurtadoIntensive Care Medicine, Universidad de Cartagena, Cartagena, COL.
Tómas Rodriguez YanezCritical Care Medicine, Universidad de Cartagena, Cartagena, COL.
Juan Camilo Gutierrez-ArizaCritical Care Medicine, Clinica La Ermita, Cartagena, COL.
Jorge Rico-FontalvoNephrology, La Asociación Colombiana de Nefrología e Hipertensión Arterial, Bogotá, COL.
University of Cartagena · COUniversidad del Sinú · COAsociación Colombiana de Nefrología e Hipertensión Arterial · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has affected millions of people, including hundreds of deaths. The search for adequate treatments and interventions that influence poor prognostic factors and reduce mortality has led to excessive use of antibiotics based on the possible existence of bacterial co-infection. However, there is no evidence to justify the systematic use of antimicrobials in COVID-19. The recommendations seek to provide knowledge regarding treatment; standardizing a management algorithm requires validation in clinical trials and studies of greater methodological rigor.

Indexed as

antibiotics therapybacterial coinfection in covid-19coronavirus disease 2019 (covid-19)sars-cov-2 (severe acute respiratory syndrome coronavirus -2)superinfection

Identifiers

PMID36046297
PMCPMC9418620
OpenAlexW4288096339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.